Ariceum Therapeutics

📢 #Ariceum is showcasing its first-in-class, lead #radiopharmaceutical drug #satoreotide in an oral presentation at the European Association of Nuclear Medicine (EANM) (#EANM) Annual Congress in Germany! 🕔 Prachi Desai, Scientist at Ariceum, will be presenting an oral presentation entitled, “²²⁵Ac-SSO110 induces long-lasting anti-tumour responses in contrast to ²²⁵Ac-DOTA-TATE and ¹⁶¹Tb-DOTA-TATE in the treatment of SSTR2-positive tumour xenografts”, at 09:00 AM – 09:10 AM CEST on Tuesday 22nd October. Session time: 08:00 AM – 09:30 AM CEST Presentation number: OP-533 Session number: 1204 Listen in as Prachi demonstrates outstanding data on #satoreotide, highlighting its potential to clinically outperform SSTR2 targeting agonists across multiple indications expressing SSTR2, including small cell lung cancer (#SCLC) and pancreatic cancers. The international scientific conference is taking place from 19-23 October in Hamburg, presenting a valuable opportunity to discuss the latest theranostic advances 🤝, impressive clinical evidence 📈, as well as recently developed #radiopharmaceuticals, novel imaging, and detection technologies.   #EANM2024 #EANM24 #biotech #oncology #lifesciences #ATT001 #ATT002 #satoreotide #oncology #cancer

Are you attending #EANO2024? Meet Austin Smith and CAROL ANDREA PREGONERO GAMEZ, PhD at the 19th Meeting of the EANO European Association of Neuro-Oncology! 📍 Austin and Carol will be in Glasgow, UK, from 17-20 October for the congress which aims to bridge gaps in the sector's understanding and management of central nervous system tumours. 💡 Get in touch to arrange a meeting with the team to find out more about Ariceum's novel iodine radiolabelled PARP inhibitor #ATT001, which is in clinical development in patients with recurrent #glioblastoma in a first-in-human Phase 1 trial, CITADEL-123. #biotech #radiopharmaceuticals #ATT001 #ATT002 #satoreotide #oncology #cancer #EANO

We're #hiring a new IT Manager (m/f/x) in Berlin. Apply today or share this post with your network.

To mark Nuclear Medicine and Molecular Imaging Week, #Ariceum celebrates its team and their contributions to developing novel #radiopharmaceuticals, a key component of #nuclearmedicine to visualize and treat #cancer. Radiopharmaceuticals are used in diagnostic imaging procedures to produce non-invasive images of organs and tissues and also to treat malignancies. The theme for this year is “See it. Believe it. Treat it." #lifesciences #biotech #ATT001 #ATT002 #oncology #radiopharmaceuticals #cancer

In our final clip from WuXi AppTec's BOLD series, Ariceum CEO, Manfred Ruediger, discusses why simple animal models are an essential prerequisite for going into the clinic with #noveldrugcandidates, stressing their importance in establishing mechanism of action and a potential starting dose. Good models for immune-related questions remain scarce however...   Manfred's full interview can be found at: https://lnkd.in/gpzns2-Q   #biotech #immunotherapy #radiopharmaceuticals

💡 This week, #Ariceum's CMO, Germo Gericke, is joining a panel discussion and will be presenting on Ariceum at the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference!   We are excited to be attending the conference, held on 26th September in New York, and look forward to an insightful discussion and networking with other attendees there!   Get in touch to organise a meeting with Ariceum at the event or to find out more about our pipeline of #radiopharmaceutical products for hard-to-treat cancers.   #lifesciences #biotech #satoreotide #ATT001 #ATT002 #oncology #radiopharmaceuticals #cancer

Make sure to see #Ariceum's Head of Procurement & Supply Chain, Erwin Bachmohr, at this year’s Targeted Radiopharmaceuticals Supply Chain & Manufacturing Summit in Boston!   📅 Erwin will be presenting and delving into the topics of 'Developing Comprehensive Risk Assessment Models for Radiopharmaceutical Development', on Thursday 26th September at 14:30 EDT.   If you are interested in meeting with Ariceum and finding out more about its novel targeted #radiopharmaceuticals to treat cancer, please get in touch!   #lifesciences #biotech #satoreotide #ATT001 #ATT002 #oncology #radiopharmaceutical #cancer #manufacturing

A review article on ⁹⁹ᵐTc-DMSA was recently published in the Journal of Nuclear Medicine Technology, helping to re-educate nuclear medicine physicians and technologists on ⁹⁹ᵐTc-DMSA.   Access the article here to find out more: https://lnkd.in/erGV2bNR   #lifesciences #biotech #nuclearmedicine #radiopharmaceuticals

In the next clip from WuXi AppTec's BOLD: Innovation That Matters series, our CEO, Manfred Ruediger, cites three of the boldest and most innovative scientific developments in the field of #cancer treatment, worthy of regaling his grandchildren with!    Watch the full interview here: https://lnkd.in/gpzns2-Q   #lifesciences #biotech #oncology #radiopharmaceuticals

What makes #Ariceum unique? 📽 Watch our CEO, Manfred Ruediger, as he explains Ariceum's differentiating approach to #radiopharmaceutical research and development through our antagonist and lead product, #satoreotide.   Manfred discusses the biology and benefits of antagonists in the WuXi AppTec's BOLD: Innovation That Matters series and provides his thoughts on what could be the next breakthrough in the radiopharma space.   View the full interview online, here: https://lnkd.in/gpzns2-Q